Showing results (681-690 of 835) with videos related to
Sort By:
Pageof 84
Blood|May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapyDavid T Teachey, Susan R Rheingold, Shannon L Maude, et al.Blood|October 26, 2016
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemiaSarah K Tasian, David T Teachey, Yong Li, et al.Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.Blood|October 11, 2007
Targeting Notch signaling in autoimmune and lymphoproliferative diseaseDavid T Teachey, Alix E Seif, Valerie I Brown, et al.Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 17, 2020
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 PandemicVeronika Bachanova, Michael R Bishop, Parastoo Dahi, et al.Plos One|August 24, 2023
Approaches and geographical locations of respectful maternity care research: A scoping reviewHannah L Shuman, Annika M Grupp, Lauren A Robb, et al.Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.Bone Marrow Transplantation|September 6, 2018
Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastomaTal Schechter, Evelio Perez-Albuerne, Tiffany F Lin, et al.Scientific Reports|November 28, 2018
FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomasKatharina Grupp, Faik Güntac Uzunoglu, Nathaniel Melling, et al.Pageof 84